NO20023709D0 - Transgen dyremodell for fedmeuttrykkende FoxC2 - Google Patents

Transgen dyremodell for fedmeuttrykkende FoxC2

Info

Publication number
NO20023709D0
NO20023709D0 NO20023709A NO20023709A NO20023709D0 NO 20023709 D0 NO20023709 D0 NO 20023709D0 NO 20023709 A NO20023709 A NO 20023709A NO 20023709 A NO20023709 A NO 20023709A NO 20023709 D0 NO20023709 D0 NO 20023709D0
Authority
NO
Norway
Prior art keywords
foxc2
human
gene
obesity
animal model
Prior art date
Application number
NO20023709A
Other languages
English (en)
Other versions
NO20023709L (no
Inventor
Sven Enerbaeck
Peter Carlsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0000531A external-priority patent/SE0000531D0/xx
Priority claimed from SE0001982A external-priority patent/SE0001982D0/xx
Priority claimed from US09/587,945 external-priority patent/US6709860B1/en
Priority claimed from SE0004629A external-priority patent/SE0004629D0/xx
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Publication of NO20023709D0 publication Critical patent/NO20023709D0/no
Publication of NO20023709L publication Critical patent/NO20023709L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20023709A 2000-02-18 2002-08-06 Transgen dyremodell for fedmeuttrykkende FOXC2 NO20023709L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0000531A SE0000531D0 (sv) 2000-02-18 2000-02-18 Animal model
SE0001982A SE0001982D0 (sv) 2000-05-26 2000-05-26 Animal model
US09/587,945 US6709860B1 (en) 1997-05-26 2000-06-06 Animal model
SE0004629A SE0004629D0 (sv) 2000-12-14 2000-12-14 Animal model III
PCT/SE2001/000339 WO2001060853A1 (en) 2000-02-18 2001-02-16 Transgenic animal model for obesity expressing foxc2

Publications (2)

Publication Number Publication Date
NO20023709D0 true NO20023709D0 (no) 2002-08-06
NO20023709L NO20023709L (no) 2002-10-17

Family

ID=27484514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023709A NO20023709L (no) 2000-02-18 2002-08-06 Transgen dyremodell for fedmeuttrykkende FOXC2

Country Status (11)

Country Link
EP (1) EP1255774B1 (no)
JP (1) JP2003523192A (no)
AT (1) ATE304552T1 (no)
AU (2) AU3259901A (no)
CA (1) CA2400342A1 (no)
DE (1) DE60113380T2 (no)
IL (1) IL150951A0 (no)
IS (1) IS6502A (no)
NO (1) NO20023709L (no)
NZ (1) NZ521005A (no)
WO (1) WO2001060853A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1320623A1 (en) * 2000-09-26 2003-06-25 Biovitrum Ab Promoter sequences
EP1468017A1 (en) * 2002-01-29 2004-10-20 Biovitrum Ab A complex of a human foxc2 protein and a foxc2-interacting protein
JPWO2005012570A1 (ja) * 2003-07-31 2007-09-27 萬有製薬株式会社 Ｓｌｃ２５ａ１０による肥満治療に有効な化合物の評価方法
JP2007519894A (ja) * 2003-12-03 2007-07-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ 標的としてのカドヘリンの使用
SE0400489D0 (sv) * 2004-02-27 2004-02-27 Biovitrum Ab Therapeutic proteins
KR101669140B1 (ko) * 2015-04-28 2016-10-26 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006104A1 (en) * 1990-09-28 1992-04-16 The Dana-Farber Cancer Institute Adipocyte-specific dna sequences and use for the production of transgenic animals exhibiting altered fat metabolism
SE9701963D0 (sv) * 1997-05-26 1997-05-26 Pharmacia & Upjohn Ab Novel transcription factor
US6087107A (en) * 1998-04-15 2000-07-11 The University Of Iowa Research Foundation Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor

Also Published As

Publication number Publication date
IS6502A (is) 2002-08-14
DE60113380D1 (de) 2005-10-20
NO20023709L (no) 2002-10-17
CA2400342A1 (en) 2001-08-23
IL150951A0 (en) 2003-02-12
ATE304552T1 (de) 2005-09-15
AU2001232599B2 (en) 2006-10-12
WO2001060853A1 (en) 2001-08-23
AU3259901A (en) 2001-08-27
EP1255774B1 (en) 2005-09-14
NZ521005A (en) 2004-04-30
JP2003523192A (ja) 2003-08-05
EP1255774A1 (en) 2002-11-13
DE60113380T2 (de) 2006-06-29

Similar Documents

Publication Publication Date Title
ATE455552T1 (de) Expression des active human factor ix im brustdrüsengewebe transgener tiere
US7744524B2 (en) Apparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules
WO2008155133A3 (en) Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
EP0591219A4 (en) Expression of active human protein c in mammary tissue of transgenic animals
DE60234111D1 (de) Abgabe von krankheitsbekämpfung in aquakultur und landwirtschaft unter verwendung von nährstoffuttermitteln, die von viren produzierte biologisch aktive proteine enthalten
IN2009DN07390A (no)
EA200700656A1 (ru) Стабильные жидкие композиции плазмидной днк
WO2004108904A3 (en) Porcine cmp-n-acetylneuraminic acid hydroxylase gene
NO20023709L (no) Transgen dyremodell for fedmeuttrykkende FOXC2
SG158115A1 (en) Transgenic animals for assessing drug metabolism and toxicity
WO2004027029A3 (en) Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells
DE69832798D1 (de) Regulatorische sequenzen für die in-vivo-expression einer heterologen dns-sequenz in endothelzellen und ihre verwendungen.
US20200044318A1 (en) Devices and Methods for the Delivery of Non-Thermal Therapeutic and Prophylactic Electromagnetic Fields from a Mobile Device
ATE552272T1 (de) Myostatin-isoform
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
DE60038508D1 (de) Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7
WO2002088378A3 (en) 66784, a novel human potassium channel and uses therefor
DE602004023927D1 (de) Ghrh zur verwendung bei der behandlung von chronischer niereninsuffizienz
CN104212807B (zh) 斜带石斑鱼orexin‑A在调控石斑鱼糖代谢中的应用
TW200600103A (en) A method for preserving platelets outside a living body
DE69940610D1 (de) Regulierende sequenzen des villin-gens aus der maus und verwendung zur herstellung von transgenen tieren
EP1151756A4 (en) USE OF POLYACRYLAMIDE GEL FOR PRODUCING A CAPSULE IN THE TISSUE OF A MAMMAL ORGANISM, METHOD FOR CULTURING CELLS AND METHOD FOR TREATING ONCOLOGICAL DISEASES AND DIABETES MELLITUS
WO2003083071A3 (en) Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
JPWO2020171118A1 (ja) 体内時計活性化システム及びその制御方法
GR1004419B (el) Μεθοδοσαελεγχουατησακυτταρικησαδιαιρεσησακαιααναπτυξης

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application